The Digital Laboratory - Rethinking Lab Notebooks in the AI Era
View as a Web Page
News Medical
 
  The Digital Laboratory The Digital Laboratory logo  
  The latest lab automation and artificial intelligence news from AZoNetwork  
 

Is Your Lab Automation Partner Good Enough?Is Your Lab Automation Partner Good Enough?

Choosing the right robotic automation partner is more important than choosing the right robot. New research from METTLER TOLEDO and ABB Robotics reveals what separates successful lab automation projects from stalled ones - from pilot design and stakeholder alignment to integration, support, and long-term scalability. Download part 3 of the free white paper series

Download Now
 
 
    Rethinking Lab Notebooks in the AI EraRethinking Lab Notebooks in the AI Era
 
AI is now part of daily lab work, but many electronic lab notebooks still do little beyond documentation. This guide explores the AI lab notebook as the next evolution of the ELN. Here you’ll find:
  • Why documentation alone no longer meets modern lab needs
  • The prevalence of unmanaged AI use in laboratories
  • How fragmented workflows drive repeated experiments
  • What scientists want from next-generation lab notebooks
 
Download the Whitepaper
 
 
   Silicon Metasurface Design Could Enable Dual-Channel Optical EncryptionSilicon Metasurface Design Could Enable Dual-Channel Optical Encryption
 
New research explores silicon nanorods in metasurfaces for polarization holographic encryption, addressing image recovery and optical performance challenges.
 
 Palmatine improved fatty liver markers in a preclinical type 2 diabetes study
 
Palmatine improved fatty liver markers in a preclinical type 2 diabetes studyResearchers used a bioinformatics-plus-rat-model approach to investigate how palmatine may help treat T2DM-associated MASLD, identifying five core targets: ADRB2, BCL3, EGR1, FOS, and MAP3K8. In rats, palmatine improved liver injury, inflammation, oxidative stress, glycolipid metabolism, steatosis, and fibrosis, while reducing apoptosis-related signaling, providing a preclinical foundation for further therapeutic study.
 
 
 Protein MIIP suppresses colorectal cancer by regulating immune cell signaling
 
Protein MIIP suppresses colorectal cancer by regulating immune cell signalingColorectal cancer remains one of the leading causes of cancer-related mortality worldwide, largely due to metastasis and limited responses to immunotherapy in most patients.
 
 
 New guidance aims to standardize tumor mutational burden in cancer
 
New guidance aims to standardize tumor mutational burden in cancerImmune checkpoint inhibitors have transformed cancer care, yet only a minority of patients respond to monotherapy, and immune-related adverse events remain a major concern.
 
 
 Study reveals ALDH2 vulnerability in APC-deficient colorectal cancer
 
Study reveals ALDH2 vulnerability in APC-deficient colorectal cancerA precision cancer strategy that selectively kills tumour cells while leaving healthy tissue intact may be within reach for the majority of colorectal cancer patients, according to new research published in Genes & Disease.
 
 
 AEGIS tool helps scientists study evolution of aging and lifespan
 
AEGIS tool helps scientists study evolution of aging and lifespanWhy do some species live for only weeks while others survive for centuries? Researchers at the Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) in Jena have developed AEGIS, a freely available software tool that enables scientists to simulate evolution on a standard computer and investigate how lifespan and aging evolve under different ecological pressures and genetic constraints.
 
 
 New computational method links individual cells to patient outcomes
 
New computational method links individual cells to patient outcomesA computational method called scSurv, developed by researchers at Institute of Science Tokyo, links individual cells to patient outcomes using widely available bulk RNA sequencing data.
 
 
 New strategy exploits specific genetic vulnerability in colorectal cancer patients
 
New strategy exploits specific genetic vulnerability in colorectal cancer patientsResearchers have identified a novel therapeutic approach for colorectal cancer by exploiting a specific genetic vulnerability found in a majority of patients.
 
 
 A New Framework for High-Efficiency Drug Development
 
A New Framework for High-Efficiency Drug DevelopmentA research team under the direction of the Medical University of Vienna has identified a potential new method for drug development in a recently published review.
 
 
 What Role Can Top-Down Proteomics Play in Fighting Disease?
 
What Role Can Top-Down Proteomics Play in Fighting Disease?By analyzing intact proteins, top-down proteomics uncovers proteoforms that influence disease, aiding in biomarker discovery and therapeutic targeting.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026